[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Placental Stem Cell Therapy Market Research Report 2023

December 2023 | 89 pages | ID: GD751FED347AEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Placental stem cells are cells derived from the placental blood and other body fluids of a new-born baby. Stem cells are human cells classified into a different variety of cell types, including brain and muscle cells. Stem cells are sometimes used in the development of regenerative therapies. Regenerative medicine represents a category of scientific alternatives to stem cell therapy (such as tissue regeneration). These treatments include the capacity to regenerate human cells, tissues, or organs to return the body to healthy working. Stem cell therapies are used to cure and improve diseases like spinal cord injuries, Parkinson's disease, heart disease, and diabetes.

According to QYResearch’s new survey, global Placental Stem Cell Therapy market is projected to reach US$ 1390.5 million in 2029, increasing from US$ 836 million in 2022, with the CAGR of 7.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Placental Stem Cell Therapy market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Placental Stem Cell Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
  • Lifebank Stem Cell Banking
  • Cynata
  • Celularity
  • Athersys
  • Americord Registry
  • ReNeuron Group
  • ReeLabs
  • Mesoblast
  • Pluristem Therapeutics
Segment by Type
  • Hematologic Malignancies and Disorders
  • Congenital Immunodeficiency Disorders
  • Metabolic Disorders
  • Neurological Disorders
  • Others
Segment by Application
  • Hospitals and Specialty Clinics
  • Clinical Research Organizations
  • Research Institutes and Academies
  • Others
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
The Placental Stem Cell Therapy report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Placental Stem Cell Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Hematologic Malignancies and Disorders
  1.2.3 Congenital Immunodeficiency Disorders
  1.2.4 Metabolic Disorders
  1.2.5 Neurological Disorders
  1.2.6 Others
1.3 Market by Application
  1.3.1 Global Placental Stem Cell Therapy Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Hospitals and Specialty Clinics
  1.3.3 Clinical Research Organizations
  1.3.4 Research Institutes and Academies
  1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Placental Stem Cell Therapy Market Perspective (2018-2029)
2.2 Placental Stem Cell Therapy Growth Trends by Region
  2.2.1 Global Placental Stem Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Placental Stem Cell Therapy Historic Market Size by Region (2018-2023)
  2.2.3 Placental Stem Cell Therapy Forecasted Market Size by Region (2024-2029)
2.3 Placental Stem Cell Therapy Market Dynamics
  2.3.1 Placental Stem Cell Therapy Industry Trends
  2.3.2 Placental Stem Cell Therapy Market Drivers
  2.3.3 Placental Stem Cell Therapy Market Challenges
  2.3.4 Placental Stem Cell Therapy Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Placental Stem Cell Therapy Players by Revenue
  3.1.1 Global Top Placental Stem Cell Therapy Players by Revenue (2018-2023)
  3.1.2 Global Placental Stem Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Placental Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Placental Stem Cell Therapy Revenue
3.4 Global Placental Stem Cell Therapy Market Concentration Ratio
  3.4.1 Global Placental Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Placental Stem Cell Therapy Revenue in 2022
3.5 Placental Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Placental Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Placental Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 PLACENTAL STEM CELL THERAPY BREAKDOWN DATA BY TYPE

4.1 Global Placental Stem Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Placental Stem Cell Therapy Forecasted Market Size by Type (2024-2029)

5 PLACENTAL STEM CELL THERAPY BREAKDOWN DATA BY APPLICATION

5.1 Global Placental Stem Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Placental Stem Cell Therapy Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Placental Stem Cell Therapy Market Size (2018-2029)
6.2 North America Placental Stem Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Placental Stem Cell Therapy Market Size by Country (2018-2023)
6.4 North America Placental Stem Cell Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Placental Stem Cell Therapy Market Size (2018-2029)
7.2 Europe Placental Stem Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Placental Stem Cell Therapy Market Size by Country (2018-2023)
7.4 Europe Placental Stem Cell Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Placental Stem Cell Therapy Market Size (2018-2029)
8.2 Asia-Pacific Placental Stem Cell Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Placental Stem Cell Therapy Market Size (2018-2029)
9.2 Latin America Placental Stem Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Placental Stem Cell Therapy Market Size by Country (2018-2023)
9.4 Latin America Placental Stem Cell Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Placental Stem Cell Therapy Market Size (2018-2029)
10.2 Middle East & Africa Placental Stem Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Lifebank Stem Cell Banking
  11.1.1 Lifebank Stem Cell Banking Company Detail
  11.1.2 Lifebank Stem Cell Banking Business Overview
  11.1.3 Lifebank Stem Cell Banking Placental Stem Cell Therapy Introduction
  11.1.4 Lifebank Stem Cell Banking Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.1.5 Lifebank Stem Cell Banking Recent Development
11.2 Cynata
  11.2.1 Cynata Company Detail
  11.2.2 Cynata Business Overview
  11.2.3 Cynata Placental Stem Cell Therapy Introduction
  11.2.4 Cynata Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.2.5 Cynata Recent Development
11.3 Celularity
  11.3.1 Celularity Company Detail
  11.3.2 Celularity Business Overview
  11.3.3 Celularity Placental Stem Cell Therapy Introduction
  11.3.4 Celularity Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.3.5 Celularity Recent Development
11.4 Athersys
  11.4.1 Athersys Company Detail
  11.4.2 Athersys Business Overview
  11.4.3 Athersys Placental Stem Cell Therapy Introduction
  11.4.4 Athersys Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.4.5 Athersys Recent Development
11.5 Americord Registry
  11.5.1 Americord Registry Company Detail
  11.5.2 Americord Registry Business Overview
  11.5.3 Americord Registry Placental Stem Cell Therapy Introduction
  11.5.4 Americord Registry Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.5.5 Americord Registry Recent Development
11.6 ReNeuron Group
  11.6.1 ReNeuron Group Company Detail
  11.6.2 ReNeuron Group Business Overview
  11.6.3 ReNeuron Group Placental Stem Cell Therapy Introduction
  11.6.4 ReNeuron Group Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.6.5 ReNeuron Group Recent Development
11.7 ReeLabs
  11.7.1 ReeLabs Company Detail
  11.7.2 ReeLabs Business Overview
  11.7.3 ReeLabs Placental Stem Cell Therapy Introduction
  11.7.4 ReeLabs Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.7.5 ReeLabs Recent Development
11.8 Mesoblast
  11.8.1 Mesoblast Company Detail
  11.8.2 Mesoblast Business Overview
  11.8.3 Mesoblast Placental Stem Cell Therapy Introduction
  11.8.4 Mesoblast Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.8.5 Mesoblast Recent Development
11.9 Pluristem Therapeutics
  11.9.1 Pluristem Therapeutics Company Detail
  11.9.2 Pluristem Therapeutics Business Overview
  11.9.3 Pluristem Therapeutics Placental Stem Cell Therapy Introduction
  11.9.4 Pluristem Therapeutics Revenue in Placental Stem Cell Therapy Business (2018-2023)
  11.9.5 Pluristem Therapeutics Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES

Table 1. Global Placental Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Hematologic Malignancies and Disorders
Table 3. Key Players of Congenital Immunodeficiency Disorders
Table 4. Key Players of Metabolic Disorders
Table 5. Key Players of Neurological Disorders
Table 6. Key Players of Others
Table 7. Global Placental Stem Cell Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Placental Stem Cell Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Placental Stem Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Placental Stem Cell Therapy Market Share by Region (2018-2023)
Table 11. Global Placental Stem Cell Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Placental Stem Cell Therapy Market Share by Region (2024-2029)
Table 13. Placental Stem Cell Therapy Market Trends
Table 14. Placental Stem Cell Therapy Market Drivers
Table 15. Placental Stem Cell Therapy Market Challenges
Table 16. Placental Stem Cell Therapy Market Restraints
Table 17. Global Placental Stem Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Placental Stem Cell Therapy Market Share by Players (2018-2023)
Table 19. Global Top Placental Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy as of 2022)
Table 20. Ranking of Global Top Placental Stem Cell Therapy Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Placental Stem Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Placental Stem Cell Therapy Product Solution and Service
Table 24. Date of Enter into Placental Stem Cell Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Placental Stem Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Placental Stem Cell Therapy Revenue Market Share by Type (2018-2023)
Table 28. Global Placental Stem Cell Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Placental Stem Cell Therapy Revenue Market Share by Type (2024-2029)
Table 30. Global Placental Stem Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Placental Stem Cell Therapy Revenue Market Share by Application (2018-2023)
Table 32. Global Placental Stem Cell Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Placental Stem Cell Therapy Revenue Market Share by Application (2024-2029)
Table 34. North America Placental Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Placental Stem Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Placental Stem Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Placental Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Placental Stem Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Placental Stem Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Placental Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Placental Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Placental Stem Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Placental Stem Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Placental Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 49. Lifebank Stem Cell Banking Company Detail
Table 50. Lifebank Stem Cell Banking Business Overview
Table 51. Lifebank Stem Cell Banking Placental Stem Cell Therapy Product
Table 52. Lifebank Stem Cell Banking Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 53. Lifebank Stem Cell Banking Recent Development
Table 54. Cynata Company Detail
Table 55. Cynata Business Overview
Table 56. Cynata Placental Stem Cell Therapy Product
Table 57. Cynata Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 58. Cynata Recent Development
Table 59. Celularity Company Detail
Table 60. Celularity Business Overview
Table 61. Celularity Placental Stem Cell Therapy Product
Table 62. Celularity Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 63. Celularity Recent Development
Table 64. Athersys Company Detail
Table 65. Athersys Business Overview
Table 66. Athersys Placental Stem Cell Therapy Product
Table 67. Athersys Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 68. Athersys Recent Development
Table 69. Americord Registry Company Detail
Table 70. Americord Registry Business Overview
Table 71. Americord Registry Placental Stem Cell Therapy Product
Table 72. Americord Registry Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 73. Americord Registry Recent Development
Table 74. ReNeuron Group Company Detail
Table 75. ReNeuron Group Business Overview
Table 76. ReNeuron Group Placental Stem Cell Therapy Product
Table 77. ReNeuron Group Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 78. ReNeuron Group Recent Development
Table 79. ReeLabs Company Detail
Table 80. ReeLabs Business Overview
Table 81. ReeLabs Placental Stem Cell Therapy Product
Table 82. ReeLabs Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 83. ReeLabs Recent Development
Table 84. Mesoblast Company Detail
Table 85. Mesoblast Business Overview
Table 86. Mesoblast Placental Stem Cell Therapy Product
Table 87. Mesoblast Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 88. Mesoblast Recent Development
Table 89. Pluristem Therapeutics Company Detail
Table 90. Pluristem Therapeutics Business Overview
Table 91. Pluristem Therapeutics Placental Stem Cell Therapy Product
Table 92. Pluristem Therapeutics Revenue in Placental Stem Cell Therapy Business (2018-2023) & (US$ Million)
Table 93. Pluristem Therapeutics Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Placental Stem Cell Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Placental Stem Cell Therapy Market Share by Type: 2022 VS 2029
Figure 3. Hematologic Malignancies and Disorders Features
Figure 4. Congenital Immunodeficiency Disorders Features
Figure 5. Metabolic Disorders Features
Figure 6. Neurological Disorders Features
Figure 7. Others Features
Figure 8. Global Placental Stem Cell Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Placental Stem Cell Therapy Market Share by Application: 2022 VS 2029
Figure 10. Hospitals and Specialty Clinics Case Studies
Figure 11. Clinical Research Organizations Case Studies
Figure 12. Research Institutes and Academies Case Studies
Figure 13. Others Case Studies
Figure 14. Placental Stem Cell Therapy Report Years Considered
Figure 15. Global Placental Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Placental Stem Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Placental Stem Cell Therapy Market Share by Region: 2022 VS 2029
Figure 18. Global Placental Stem Cell Therapy Market Share by Players in 2022
Figure 19. Global Top Placental Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Placental Stem Cell Therapy Revenue in 2022
Figure 21. North America Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Placental Stem Cell Therapy Market Share by Country (2018-2029)
Figure 23. United States Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Placental Stem Cell Therapy Market Share by Country (2018-2029)
Figure 27. Germany Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Placental Stem Cell Therapy Market Share by Region (2018-2029)
Figure 35. China Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Placental Stem Cell Therapy Market Share by Country (2018-2029)
Figure 43. Mexico Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Placental Stem Cell Therapy Market Share by Country (2018-2029)
Figure 47. Turkey Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Placental Stem Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Lifebank Stem Cell Banking Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 50. Cynata Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 51. Celularity Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 52. Athersys Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 53. Americord Registry Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 54. ReNeuron Group Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 55. ReeLabs Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 56. Mesoblast Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 57. Pluristem Therapeutics Revenue Growth Rate in Placental Stem Cell Therapy Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed


More Publications